Last week the U.S. Food and Drug Administration approved the first treatment ever for advanced stomach cancer that has not responded to chemotherapy. Charles Fuchs, professor of medicine at the Dana-Farber Cancer Institute, is the lead investigator of the medication, called Cyramza.
Scientists affiliated with the Personal Genome Project, a research effort to find 100,000 volunteers as research subjects in the public domain — contributing data from their genomes, microbiomes, health records, tissues and more, are meeting today for the fifth annual GET conference; the initials stand for genomes, environments and traits. Research by George Church, the Robert Winthrop Professor of Genetics, and Abigail Wark, research fellow in genetics, is cited.
New research showing a link between depression medication and early births highlights the need for women to talk with their doctors before taking one of the drugs during pregnancy, physicians say. Krista Huybrechts, assistant professor of medicine at Brigham and Women’s Hospital, led the study.
Scientists have used cloning technology to make stem cells from a woman with Type 1 diabetes that are genetically matched to her and to her disease. Douglas Melton, the Xander University Professor of Stem Cell and Regenerative Biology and co-director of the Harvard Stem Cell Institute, is quoted.
Christoph Westphal, a member of the HMS Board of Fellows, authored this opinion piece about how many hepatitis C patients now have the hope of receiving a therapy that can completely cure them of their infection.
New research shows the best business minds make decisions very differently than we thought. Srini Pillay, assistant clinical professor of psychiatry at McLean Hospital, is quoted.
